ARCHIVES

In Brief: NCI Claim “Major Finding” In Treatment Of Soft Tissue Sarcoma With Three Modalities; 93% Survival

This article is from The Cancer Letter archive.

Vol. 07 No. 41 | October 9, 1981

Download PDF Visit The Full Archive

Related Articles

NIH Carcinogen Guidelines Offered

April 24, 1981

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003

Funding Opportunities: HHMI Commits $300M To Support Early Career Scientists.

March 21, 2008

No Longer A Hands-Off Shareholder, Roche Seeks Full Control Of Genentech.

July 25, 2008

In Brief: NSABP Proposal Selected for Tamoxifen Trials; NIH Building To Be Named After Silvio Conte

March 8, 1991

Patients Prefer Silicone Over Saline Implants

November 26, 2010